Maternal Metformin Treatment Improves Developmental and Metabolic Traits of IUGR Fetuses

Metformin is an anti-hyperglycemic drug widely used for the treatment of insulin resistance and glucose intolerance and is currently considered for preventing large-for-gestational-age (LGA) offspring in pregnant women affected by obesity or diabetes. Our hypothesis was the opposite—metformin may be...

Descripción completa

Detalles Bibliográficos
Autores principales: Garcia-Contreras, Consolación, Vazquez-Gomez, Marta, Pesantez-Pacheco, José Luis, Torres-Rovira, Laura, Heras-Molina, Ana, Encinas, Teresa, Astiz, Susana, Gonzalez-Bulnes, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6572102/
https://www.ncbi.nlm.nih.gov/pubmed/31035702
http://dx.doi.org/10.3390/biom9050166

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6572102/
https://www.ncbi.nlm.nih.gov/pubmed/31035702
http://dx.doi.org/10.3390/biom9050166

Ejemplares similares